Peter Attia· MD
Tom forty Tom forty has we don't have a commercial test that we can test for it there is a way to do it if we send it somewhere but we really never went there
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Tom forty Tom forty has we don't have a commercial test that we can test for it there is a way to do it if we send it somewhere but we really never went there
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there are a bunch of other genes that we're now starting to understand modify the risk of e4 some things make it more significant some things make it less so there are certain haplotypes of the tom 40 gene that amplify risk there are certain mitochondrial haplotypes that amplify risk